VTR Company Profile and Key Details

Q: Who are the executives of VTR?

Mr. Gregory R. LiebbeSenior Vice President, Chief Accounting Officer & ControllerMr. Ankit PatelSVice President of Corporation Fin. & Head of IRMs. Debra A. CafaroChairman & Chief Executive OfficerMr. Edmund M. Brady IIIChief HR Officer & Senior Vice PresidentMr. J. Justin HutchensExecutive Vice President of Senior Housing & Chief Investment OfficerMr. John D. CobbStrategic AdvisorMr. T. Richard Riney J.D.Senior AdvisorMs. Carey Shea Roberts J.D.Executive Vice President, Gen. Counsel, Corporation Sec. and Ethics & Compliance OfficerMs. Louise AdhikariVice President of Marketing & Corporation CommunicationsMs. Bhavana DevulapallySenior Vice President & Chief Information OfficerMr. Robert F. ProbstExecutive Vice President & Chief Financial OfficerMr. Peter J. BulgarelliExecutive Vice President of Office

NYSE : VTR

Ventas

$82.18

0.33+0.40%

At Close 4:00 PM

63.39

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Ventas, Inc. (VTR) stock surged +0.40%, trading at $82.18 on NYSE, up from the previous close of $81.85. The stock opened at $81.59, fluctuating between $81.26 and $83.16 in the recent session.

Stock Snapshot

81.85

Prev. Close

39.03B

Market Cap

81.26

Day Low

152.19

P/E Ratio

0.54

EPS (TTM)

1.96

Cash Flow per Share

81.59

Open

474.97M

Number of Shares

83.155

Day High

99.48%

Free Float in %

23.54

Book Value

2.69M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 24, 2026	81.59	83.16	81.26	82.18	2.69M
Mar 23, 2026	83.43	84.03	81.76	81.85	2.79M
Mar 20, 2026	85.55	85.69	81.96	82.50	6.18M
Mar 19, 2026	87.25	87.96	85.44	85.55	3.08M
Mar 18, 2026	87.94	88.37	86.99	87.33	3.36M
Mar 17, 2026	88.08	88.21	87.33	88.00	2.54M
Mar 16, 2026	87.64	88.23	87.33	87.79	3.01M
Mar 13, 2026	87.02	87.38	86.23	86.56	6.81M
Mar 12, 2026	86.01	86.88	84.86	86.20	4.14M
Mar 11, 2026	85.56	86.36	85.31	85.81	1.85M
Mar 10, 2026	85.94	87.17	85.51	86.08	2.24M
Mar 09, 2026	84.37	86.34	83.80	86.21	1.72M
Mar 06, 2026	84.32	85.19	83.96	84.87	2.28M
Mar 03, 2026	85.74	86.83	85.02	86.50	1.71M
Mar 02, 2026	86.57	86.94	85.96	86.66	2.17M
Feb 27, 2026	86.74	87.87	85.93	86.16	6.96M
Feb 26, 2026	86.68	86.98	86.18	86.44	2.07M
Feb 25, 2026	86.40	87.07	85.85	86.41	1.77M
Feb 24, 2026	86.47	86.87	85.65	86.43	2.41M
Feb 23, 2026	86.15	86.99	85.93	86.62	2.36M

Contact Details

Chicago, IL 60654

United States

https://www.ventasreit.com 877 483 6827

About Company

Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.

Stock Peers

WELL

1.61+0.83%

Welltower Inc.$196.61 NHI

0.24+0.29%

National Health Investors, Inc.$82.56 AHR

0.18+0.37%

American Healthcare REIT, Inc.$48.25 OHI

-0.11-0.25%

Omega Healthcare Investors, Inc.$44.73 UHT

-0.57-1.40%

Universal Health Realty Income Trust$40.09 LTC

0.66+1.80%

LTC Properties, Inc.$37.35 CTRE

-0.31-0.83%

CareTrust REIT, Inc.$37.14 GMRE

-0.45-1.24%

Global Medical REIT Inc.$35.74 GMRE-PA

-0.26-1.04%

Global Medical REIT Inc.$24.63 SILA

Sila Realty Trust, Inc.$24.00

Company Overview

Ventas, Inc. (NYSE:VTR) closed at $82.18 USD, gaining $0.33 (0.40%) from the previous close of $81.85. The stock is currently mid-range between its 52-week high and low $60.15 and $88.37. With a market capitalization of about $39.03 billion, Ventas, Inc. is classified as a large-cap and shows lower-than-market volatility (beta ~0.76). Key stats such as the average daily volume over the past year has been around 2.92 million shares, in line with its 52-week average. Headquartered in Chicago, IL, Ventas, Inc. operates in the Real Estate sector and the REIT - Healthcare Facilities industry. Led by CEO Debra A. Cafaro, the company employs approximately 498 people and listed since May 05, 1997. Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate.

Technical Performance

VTR has shown sold momentum, gaining 3.3% over the past week and 10.71% over the past quarter, though year-to-date performance is up 1.03%. Short-term trend indicators are bearishly aligned (SMA20 3.99%, SMA50 8.35%, SMA200 20.58%). The stock’s 14-day RSI is 72.49 (overbought), while the ATR of 1.53 points to moderate volatility. The stock remains sitting in the mid-range of its 52-week band, trading -0.92% below its high and over 43.71% above its low. Average 10-day trading volume of 3.38 million shares is slightly above the 3-month average of 2.91 million, indicating heightened recent market interest.

Valuation Metrics

Ventas, Inc. trades at a P/E ratio of 155.28, slightly above the S&P 500 average, with a price-to-sales ratio of 6.75 and a price-to-book ratio of 3.12 trading at moderately above to book value. The P/FCF stands at 29.89, also above market averages.

Dividend & Fair Value

Ventas, Inc. last paid a dividend of 1.92 per share, this equals a trailing yield of roughly 2.83%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $119.51. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Ventas, Inc. generated EPS of $0.54 over the past year. Five-year average earnings growth is -14.17%. Wall Street analysts project EPS growth of 36.51% annually over the next five years. The latest quarter delivered EPS of $0.14. The next quarter is forecast at $0.11. Next year's EPS is expected at -$640.55. Analyst sentiment is bullish. Analyst rating data shows there are 15 Strong Buy ratings, 3 Buy ratings, 6 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $96.00 to $72.00. The high target offers 16.82% upside. The low target suggests -12.39% downside. The mean target is $82.62. This offers 0.54% upside. Ventas, Inc. earnings surprise history is a mixed track record. The quarter that ended October 29, 2025, missed forecasts by -83.91%. The prior quarter beat by 2.35%. Over the last six quarters, Apple has recorded several small beats. These include -93.67% in August 01, 2024.

Shareholding & Insider Activity

Ventas, Inc. has 454.47 million shares outstanding. The public float is 452.10 million shares, elevated short interest at 3.99% of float. This equals 15.50 million shares. The short ratio is 5.67 days. Institutional investors hold 100.82% of the float. Insiders own 0.52%. CAFARO DEBRA A holds 1.11 million shares, LEWIS RAYMOND J has 170.63 thousand shares and SCHWEINHART RICHARD A has 140.63 thousand shares. Over the past six months, insider transactions show net selling. They sold 506.43 thousand shares across 23 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Ventas generated $4.50B in revenue, or $11.19 per share. Gross margin was 17.14%, operating margin 14.79%, and net profit margin -0.91%. Returns are negative, with ROA at -0.17% and ROE at -0.43%.
On valuation metrics, Ventas trades at a P/E of 155.28, P/S of 6.75 and P/B of 3.12. Liquidity is tight, with a current ratio of 0.96 and quick ratio of 0.96. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is -47.31 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 1.06, supported by a cash flow-to-debt ratio of 0.13.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Ventas posted revenue of $4.50B, down slightly from $4.13B in the prior quarter. Gross profit was $770.72M (margin 17.14%). Operating income was $665.12M (margin 14.8%). Net income was- $40.97M (EPS - $0.10).
The company ended the quarter with $563.46M in cash and short-term investments, a total debt of $13.77B, and net debt of $13.20B. Total assets were $24.73B, with equity of $9.85B. Financials further reflected stability, with operating cash flow of $1.19B, free cash flow of $935.13M, and capital expenditures of - $259.42M.

Price Forecast & Outlook

Our AI price prediction model suggests that Ventas, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.46%, with price expected at $82.56 by April 06, 2026, within a range of $81.18 to $83.99 3-Month Outlook: Projected rise of 3.82%, reaching $85.32 by June 19, 2026, with a range of $83.84 to $86.82. 1-Year Outlook: Projected gain of 20.49%, with price at $99.02 by March 23, 2027, within a range of $97.33 to $100.99.

Key Takeaways

Ventas, Inc. (NYSE:VTR) shares are flat 1.03% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Ventas, Inc. trading at a premium to the broader market with a P/E of 155.28. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $66.72, suggesting -18.81% downside. Our AI forecast model points to short-term strength (0.46% over two weeks), a medium-term rise (3.82% over three months), and a longer-term gain (20.49% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Ventas, Inc. (VTR) stock price?

Ventas, Inc. (NYSE: VTR) stock price is $82.18 in the last trading session. During the trading session, VTR stock reached the peak price of $83.16 while $81.26 was the lowest point it dropped to. The percentage change in VTR stock occurred in the recent session was 0.4% while the dollar amount for the price change in VTR stock was $0.33.

VTR's industry and sector of operation?

The NYSE listed VTR is part of REIT - Healthcare Facilities industry that operates in the broader Real Estate sector. Ventas, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of VTR?

Mr. Gregory R. Liebbe
Senior Vice President, Chief Accounting Officer & Controller
Mr. Ankit Patel
SVice President of Corporation Fin. & Head of IR
Ms. Debra A. Cafaro
Chairman & Chief Executive Officer
Mr. Edmund M. Brady III
Chief HR Officer & Senior Vice President
Mr. J. Justin Hutchens
Executive Vice President of Senior Housing & Chief Investment Officer
Mr. John D. Cobb
Strategic Advisor
Mr. T. Richard Riney J.D.
Senior Advisor
Ms. Carey Shea Roberts J.D.
Executive Vice President, Gen. Counsel, Corporation Sec. and Ethics & Compliance Officer
Ms. Louise Adhikari
Vice President of Marketing & Corporation Communications
Ms. Bhavana Devulapally
Senior Vice President & Chief Information Officer
Mr. Robert F. Probst
Executive Vice President & Chief Financial Officer
Mr. Peter J. Bulgarelli
Executive Vice President of Office

How VTR did perform over past 52-week?

VTR's closing price is 36.62% higher than its 52-week low of $60.15 where as its distance from 52-week high of $88.37 is -7%.

How many employees does VTR have?

Number of VTR employees currently stands at 498.

Link for VTR official website?

Official Website of VTR is: https://www.ventasreit.com

How do I contact VTR?

VTR could be contacted at phone 877 483 6827 and can also be accessed through its website. VTR operates from 353 North Clark Street, Chicago, IL 60654, United States.

How many shares of VTR are traded daily?

VTR stock volume for the day was 2.69M shares. The average number of VTR shares traded daily for last 3 months was 2.92M.

What is the market cap of VTR currently?

The market value of VTR currently stands at $39.03B with its latest stock price at $82.18 and 474.97M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	498
Beta	0.76
Sales or Revenue	$4.50B
5Y Sales Change%	0.065%
Fiscal Year Ends	December
Sector	Real Estate
Industry	REIT - Healthcare Facilities

VTR Company Profile and Key Details

Ventas

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Company Overview

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Dividend & Fair Value

Price Forecast & Outlook

Key Takeaways